Clinical Trials & Research

While reports on deaths are depressing, they can be incredibly interesting as well. They reflect trends in population health and help to target areas for health interventions. The latest report from the Australian Institute of Health and Welfare reveals that more than 18,000 Australians died of coronary heart disease, or heart attacks, in 2017. While
0 Comments
The UPV/EHU-University of the Basque Country analyses the high capacity of A. baumannii, the possible cause of recurring outbreaks in ICUs, to persist on various surfaces. A group in the Department of Immunology, Microbiology and Parasitology at the UPV/EHU has conducted an in-depth study into the capacity to survive of the Acinetobacter baumannii bacterium as
0 Comments
Jul 15 2019 Bordeaux University Hospital (CHU) in France is leading the charge to improve success rates of complex kidney tumor removal surgery, thanks to unique full-color, multi-material 3D printing technology. The CHUis currently one of the only hospitals worldwide to use a Stratasys J750– the world’s only full-color, multi-material 3D printer – for complex
0 Comments
Jul 15 2019 Working closely with a medical device manufacturer, Porvair Sciences has developed a high-performance fluid collection vent for a surgical suction cannister using their proprietary Vyon® porous plastic. A large fraction of the waste produced during surgery is in the form of liquids such as blood and bodily fluids that have been diverted
0 Comments
Jul 15 2019 Researchers at Okayama University have developed an early gastric cancer endoscopic diagnosis system using artificial intelligence (AI). The details were presented at the Congress of the Japan Gastroenterological Endoscopy Society (JGES), May 31 – June 2, 2019, Tokyo. The image of Endoscopic diagnosis system using AI. According to data released in 2017
0 Comments
Researchers from Medical University of South Carolina (MUSC) have discovered the use of thioredoxin – a naturally occurring antioxidant to modulate T cells of the immune system. This may be a big step towards improving currently used immune therapies such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT). The studies were funded
0 Comments
Laboratory and animal studies have suggested that the leukemia drug nilotinib could alleviate symptoms of Parkinson’s disease. Now, using early results from a clinical trial in humans, scientists have worked out how the drug reduces toxic protein and raises dopamine levels in the brain. New research explains how a cancer drug increases levels of the
0 Comments
Researchers have found that Schwann cells, a special type of cells are capable of generating protective myelin sheath covers for the nerves at rates higher than earlier believed. Senior author Dr. Kelly Monk, professor and co-director of the Vollum Institute at Oregon Health & Science University said in a statement, “This totally overturns the textbook
0 Comments
Researchers at LSTM, along with colleagues at the University of Edinburgh and the University Medical Center Utrecht have looked at the impact of the natural microbial flora or microbiota in the nose and viral co-infection on pneumococcal acquisition in healthy adults. Streptococcus pneumoniae or pneumococcus is the main bacterial pathogen involved in pneumonia, a respiratory
0 Comments
A study by the UPV/EHU’s Department of Evolutionary Psychology and Education has explored the validity of narrative and non-narrative cartoons for developing narrative skills, moral reasoning and values and countervalues in children in mainstream and non-mainstream education. The effect that may be exerted by the structure of the cartoons on these aspects when the children
0 Comments
The findings of a new study suggest that people who receive highly personalized combination therapy for treatment-resistant cancer can experience improved disease control and survival rates. Can highly personalized precision medicine bring more benefits to people with metastatic cancer? Recently, precision medicine has been gaining ground as a potentially more effective approach to treating a
0 Comments
For decades medical researchers have known that an effective way to combat multiple sclerosis (MS) would be to suppress the human immune system, since the debilitating disease is caused by the immune system ‘mistakenly’ attacking tissues in the spine and brain. However, this kind of treatment would cripple the body’s ability to control ordinary infections,
0 Comments
Antidepressants reduce deaths by more than a third in patients with diabetes and depression, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes are two to three times more likely to have depression than people without diabetes, according to the U.S. Centers for Disease Control and
0 Comments
In 2007, Patrice Cani (FNRS-WELBIO researcher) and his team at the Louvain Drug Research Institute of University of Louvain, in close collaboration with Willem de Vos, professor at UWageningen, discovered the beneficial effects of an intestinal bacteria, Akkermansia muciniphila, able to moderate the development of obesity and type 2 diabetes, in mice. In 2017, the
0 Comments
A recent Multiple Sclerosis Journal study that included data from 281 patients and 609 surgeries suggests post-operative MS relapse risk does not significantly differ from pre-operative relapse risk. No prior studies have systematically investigated the influence of surgery or anesthesia administration on relapse risk, but it’s a large concern in clinical practice. This concern greatly
0 Comments